Azeem Sharda

866 total citations
11 papers, 359 citations indexed

About

Azeem Sharda is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Azeem Sharda has authored 11 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Hematology. Recurrent topics in Azeem Sharda's work include Cancer, Hypoxia, and Metabolism (4 papers), Immunotherapy and Immune Responses (3 papers) and Acute Myeloid Leukemia Research (2 papers). Azeem Sharda is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Immunotherapy and Immune Responses (3 papers) and Acute Myeloid Leukemia Research (2 papers). Azeem Sharda collaborates with scholars based in United States, Sweden and China. Azeem Sharda's co-authors include David T. Scadden, Angelo S. Mao, David Mooney, Nisarg J. Shah, Ting‐Yu Shih, Alexander J. Najibi, Nick van Gastel, Yiping Wang, Theresa M. Raimondo and Shuangnian Xu and has published in prestigious journals such as Blood, Nature Biotechnology and Cell Metabolism.

In The Last Decade

Azeem Sharda

11 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Azeem Sharda United States 5 181 125 87 74 72 11 359
Lindsey T. Brinton United States 10 338 1.9× 66 0.5× 56 0.6× 46 0.6× 75 1.0× 18 458
Martha Lopez‐Yrigoyen United Kingdom 7 166 0.9× 173 1.4× 74 0.9× 29 0.4× 33 0.5× 10 337
Maria Teresa Palano Italy 11 121 0.7× 87 0.7× 82 0.9× 20 0.3× 48 0.7× 17 264
Yuanzheng Liang China 3 177 1.0× 234 1.9× 129 1.5× 37 0.5× 15 0.2× 8 388
Pia Sommerkamp Germany 7 141 0.8× 242 1.9× 95 1.1× 30 0.4× 54 0.8× 14 394
Amit Mandoli Netherlands 10 363 2.0× 47 0.4× 123 1.4× 28 0.4× 103 1.4× 19 607
Livingstone Fultang United Kingdom 7 153 0.8× 219 1.8× 216 2.5× 54 0.7× 37 0.5× 8 458
Vincenzo Ingangi Italy 12 142 0.8× 102 0.8× 120 1.4× 33 0.4× 16 0.2× 15 323
Brandon McCluskey United States 6 145 0.8× 83 0.7× 200 2.3× 25 0.3× 121 1.7× 9 376

Countries citing papers authored by Azeem Sharda

Since Specialization
Citations

This map shows the geographic impact of Azeem Sharda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azeem Sharda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azeem Sharda more than expected).

Fields of papers citing papers by Azeem Sharda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azeem Sharda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azeem Sharda. The network helps show where Azeem Sharda may publish in the future.

Co-authorship network of co-authors of Azeem Sharda

This figure shows the co-authorship network connecting the top 25 collaborators of Azeem Sharda. A scholar is included among the top collaborators of Azeem Sharda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azeem Sharda. Azeem Sharda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
He, Lingli, Ting Zhao, Wei Zhong Leong, et al.. (2024). AML Stem Cell Clearance By Inhibiting Selenoprotein Biosynthesis That Causes Cgas-Sting Activation and Ferroptosis. Blood. 144(Supplement 1). 1354–1354. 1 indexed citations
2.
Mazzola, Michael, Ting C. Zhao, Trine Kristiansen, et al.. (2022). Cap-Independent Protein Translation in Hematopoiesis. Blood. 140(Supplement 1). 1983–1984. 1 indexed citations
3.
Wang, Yiping, Azeem Sharda, Shuangnian Xu, et al.. (2021). Malic enzyme 2 connects the Krebs cycle intermediate fumarate to mitochondrial biogenesis. Cell Metabolism. 33(5). 1027–1041.e8. 60 indexed citations
4.
Najibi, Alexander J., Nisarg J. Shah, Ting‐Yu Shih, et al.. (2021). Abstract PO085: Cryogel-based cancer vaccine to treat acute myeloid leukemia. Cancer Immunology Research. 9(2_Supplement). PO085–PO085. 1 indexed citations
5.
Shah, Nisarg J., Alexander J. Najibi, Ting‐Yu Shih, et al.. (2020). A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia. Nature Biomedical Engineering. 4(1). 40–51. 96 indexed citations
6.
Gastel, Nick van, Jessica B. Spinelli, Azeem Sharda, et al.. (2020). Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance. Cell Metabolism. 32(3). 391–403.e6. 94 indexed citations
7.
Gastel, Nick van, Jessica B. Spinelli, Azeem Sharda, et al.. (2020). Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance. SSRN Electronic Journal. 3 indexed citations
8.
Shah, Nisarg J., Angelo S. Mao, Ting‐Yu Shih, et al.. (2019). An injectable bone marrow–like scaffold enhances T cell immunity after hematopoietic stem cell transplantation. Nature Biotechnology. 37(3). 293–302. 84 indexed citations
9.
Gastel, Nick van, Jessica B. Spinelli, Azeem Sharda, et al.. (2019). The Distinctive Metabolic Environment of the Bone Marrow Niche Drives Leukemia Chemoresistance. Blood. 134(Supplement_1). 3725–3725. 1 indexed citations
10.
Sharda, Azeem, Rod R. Warburton, Ellen O. Weinberg, et al.. (2018). A purinergic P2Y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma. Journal of Asthma and Allergy. Volume 11. 159–171. 16 indexed citations
11.
Gastel, Nick van, Amir Schajnovitz, Charles Vidoudez, et al.. (2017). Untargeted Metabolomics Identifies Glutamine Metabolism As a Driver of Chemoresistance in Acute Myeloid Leukemia. Blood. 130. 2523–2523. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026